Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (1501-1510 of 6,943) with videos related to

Pageof 695
Sort By:
Cancer Science|February 26, 2015
Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft modelsYoshiyuki Yamamoto, Ichinosuke Hyodo, Yoshikatsu Koga, et al.
Cancer Science|March 5, 2015
Suppression of silent information regulator 1 activity in noncancerous tissues of hepatocellular carcinoma: Possible association with non-B non-C hepatitis pathogenesisHideyuki Konishi, Ken Shirabe, Hidekazu Nakagawara, et al.
Cancer Science|April 2, 2015
ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinomaGuiming Zhang, Chengyuan Gu, Yao Zhu, et al.
Cancer Science|April 10, 2015
Antitumor activity of the MEK inhibitor trametinib on intestinal polyp formation in Apc(Δ716) mice involves stromal COX-2Teruaki Fujishita, Rie Kajino-Sakamoto, Yasushi Kojima, et al.
Cancer Science|July 9, 2020
Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancerYunlong Hu, Mingzhou Guo
Cancer Science|July 9, 2020
Report of the use of patient-derived xenograft models in the development of anticancer drugs in JapanRyo Tsumura, Yoshikatsu Koga, Akinobu Hamada, et al.
Cancer Science|June 27, 2020
Novel enhanced GFP-positive congenic inbred strain establishment and application of tumor-bearing nude mouse modelQing Lan, Yanming Chen, Chungang Dai, et al.
Cancer Science|June 27, 2020
ZNF251 promotes the progression of lung cancer by activating ERK signalingChenxi Zhong, Chunji Chen, Feng Yao, et al.
Cancer Science|June 27, 2020
Novel cucurmosin-based immunotoxin targeting programmed cell death 1-ligand 1 with high potency against human tumor in vitro and in vivoCaiyun Zhang, Jiani Xiong, Yinxiang Lan, et al.
Cancer Science|April 14, 2015
Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumorsWeidang Wu, Yan Dong, Jing Gao, et al.
Pageof 695

Showing results (1501-1510 of 6,943) with videos related to

Sort By:
Pageof 695
Cancer Science|February 26, 2015
Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft modelsYoshiyuki Yamamoto, Ichinosuke Hyodo, Yoshikatsu Koga, et al.
Cancer Science|March 5, 2015
Suppression of silent information regulator 1 activity in noncancerous tissues of hepatocellular carcinoma: Possible association with non-B non-C hepatitis pathogenesisHideyuki Konishi, Ken Shirabe, Hidekazu Nakagawara, et al.
Cancer Science|April 2, 2015
ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinomaGuiming Zhang, Chengyuan Gu, Yao Zhu, et al.
Cancer Science|April 10, 2015
Antitumor activity of the MEK inhibitor trametinib on intestinal polyp formation in Apc(Δ716) mice involves stromal COX-2Teruaki Fujishita, Rie Kajino-Sakamoto, Yasushi Kojima, et al.
Cancer Science|July 9, 2020
Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancerYunlong Hu, Mingzhou Guo
Cancer Science|July 9, 2020
Report of the use of patient-derived xenograft models in the development of anticancer drugs in JapanRyo Tsumura, Yoshikatsu Koga, Akinobu Hamada, et al.
Cancer Science|June 27, 2020
Novel enhanced GFP-positive congenic inbred strain establishment and application of tumor-bearing nude mouse modelQing Lan, Yanming Chen, Chungang Dai, et al.
Cancer Science|June 27, 2020
ZNF251 promotes the progression of lung cancer by activating ERK signalingChenxi Zhong, Chunji Chen, Feng Yao, et al.
Cancer Science|June 27, 2020
Novel cucurmosin-based immunotoxin targeting programmed cell death 1-ligand 1 with high potency against human tumor in vitro and in vivoCaiyun Zhang, Jiani Xiong, Yinxiang Lan, et al.
Cancer Science|April 14, 2015
Aspartate-modified doxorubicin on its N-terminal increases drug accumulation in LAT1-overexpressing tumorsWeidang Wu, Yan Dong, Jing Gao, et al.
Pageof 695